insights_auto
Miks on NVSEF tõusnud? 2,28%?
Uurige põhjalikumaltchevron_right
NVSEF:OTCMKTS
Novartis AG
143,18 $
arrow_upward
+2,28%(+3,20) 1 p
12. okt, 16:00:00 GMT −4 · USD
search
Kõik sümbolid
| Sümbol | Hind | Muutus | % muutus |
|---|
insights_autoÜksuse NVSEF põhistatistika genereerimine…
Ava
143,18 $
Kõrge
143,18 $
Madal
143,18 $
Turu kapit.
292,13 mld
Keskm. maht
30,94 tuh
Maht
351,00
52 näd kõrgeim
171,29 $
52 näd madalaim
120,00 $
Beeta
0,40
Käibivad aktsiad
2,03 mld
Töötajate arv
75 tuh
Ava
143,18 $
Kõrge
143,18 $
Madal
143,18 $
Turu kapit.
292,13 mld
Keskm. maht
30,94 tuh
Maht
351,00
52 näd kõrgeim
171,29 $
52 näd madalaim
120,00 $
Beeta
0,40
Käibivad aktsiad
2,03 mld
Töötajate arv
75 tuh
Uudised
Veebiallikatest ja uudistepartneritelt
ad-hoc-news.de
·
4 tunni eest
Novartis stock pre-market at EUR 128.74
ad-hoc-news.de
·
6 tunni eest
DKSH expands Novartis partnership as seven analysts track DKSH stock
marketscreener.com
·
18 tunni eest
Swiss Blue-chip Index Starts Week Upbeat; Roche, Novartis Shares Gain
ad-hoc-news.de
·
23 tunni eest
Novartis stock trades at EUR 128.57 with volume 3.2 percent below average
Profiil
Novartis AG is a Swiss multinational pharmaceutical corporation based in Basel, Switzerland. Novartis is one of the largest pharmaceutical companies in the world and was the eighth largest by revenue in 2024.
Novartis manufactures the drugs clozapine, diclofenac, carbamazepine, valsartan, imatinib mesylate, cyclosporine, letrozole, methylphenidate, terbinafine, deferasirox, and others.
Novartis was formed in 1996 by the merger of Ciba-Geigy and Sandoz. It was considered the largest corporate merger in history during that time. The pharmaceutical and agrochemical divisions of both companies formed Novartis as an independent entity. The name Novartis was based on the Latin terms, novae artes.
After the merger, other Ciba-Geigy and Sandoz businesses were sold, or, like Ciba Specialty Chemicals, spun off as independent companies. The Sandoz brand disappeared for three years, but was revived in 2003 when Novartis consolidated its generic drugs businesses into a single subsidiary and named it Sandoz. Wikipedia
Teave üksuse Novartis AG kohta
TegevjuhtVasant Narasimhan
Töötajad75,3 tuh
Asutatud7. märts 1996
PeakontoridBasel, Basel, Šveits
Sektor-
Veebisaitnovartis.com